Issue navigation
Volume 106, Issue 10, October 2014
Cover
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, djt382, https://doi.org/10.1093/jnci/djt382
Editorial_Board
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, djt383, https://doi.org/10.1093/jnci/djt383
Table_of_Contents
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, djt385, https://doi.org/10.1093/jnci/djt385
Discussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal Cancer
Kenneth L. Kehl and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju216, https://doi.org/10.1093/jnci/dju216
Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium
Julie R. Palmer and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju237, https://doi.org/10.1093/jnci/dju237
The Relationship Between Quality, Spending, and Outcomes Among Women With Breast Cancer
Michael J. Hassett and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju242, https://doi.org/10.1093/jnci/dju242
Test of Four Colon Cancer Risk-Scores in Formalin Fixed Paraffin Embedded Microarray Gene Expression Data
Antonio F. Di Narzo and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju247, https://doi.org/10.1093/jnci/dju247
Comparison of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After Multimodality Treatment
Atthaphorn Trakarnsanga and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju248, https://doi.org/10.1093/jnci/dju248
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju249, https://doi.org/10.1093/jnci/dju249
Prevalence of Mammographically Dense Breasts in the United States
Brian L. Sprague and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju255, https://doi.org/10.1093/jnci/dju255
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers
Julian C. Schink and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju256, https://doi.org/10.1093/jnci/dju256
The Role of MicroRNAs in the Control of Innate Immune Response in Cancer
Simon Jasinski-Bergner and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju257, https://doi.org/10.1093/jnci/dju257
Use of Crowdsourcing for Cancer Clinical Trial Development
Amanda Leiter and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju258, https://doi.org/10.1093/jnci/dju258
Analysis of Serial Ovarian Volume Measurements and Incidence of Ovarian Cancer: Implications for Pathogenesis
Clara Bodelon and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju262, https://doi.org/10.1093/jnci/dju262
Discussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal Cancer
Anneke T. Schroen and Craig L. Slingluff
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju265, https://doi.org/10.1093/jnci/dju265
Measure for Measure: The Cost of Improving Quality
Jason D. Wright and Dawn L. Hershman
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju266, https://doi.org/10.1093/jnci/dju266
Lineages of Oncogenic Human Papillomavirus Types Other Than Type 16 and 18 and Risk for Cervical Intraepithelial Neoplasia
Long Fu Xi and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju270, https://doi.org/10.1093/jnci/dju270
RE: External Validity of a Trial Comprised of Elderly Patients With Hormone Receptor-Positive Breast Cancer
Noel S. Weiss
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju271, https://doi.org/10.1093/jnci/dju271
Response
Willemien van de Water and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju272, https://doi.org/10.1093/jnci/dju272
Breastfeeding and Triple-Negative Breast Cancer: Potential Implications for Racial/Ethnic Disparities
Amanda I. Phipps and Christopher I. Li
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju281, https://doi.org/10.1093/jnci/dju281
So Much Effort, So Little Progress?
Heinz-Josef Lenz and Sebastian Stintzing
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju282, https://doi.org/10.1093/jnci/dju282
Pharmacological Relevance of Endoxifen in a Laboratory Simulation of Breast Cancer in Postmenopausal Patients
Philipp Y. Maximov and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju283, https://doi.org/10.1093/jnci/dju283
Identifying the Most Predictive Post-Chemoradiation TRG System for Rectal Cancer
Bruce D. Minsky and Claus Rodel
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju285, https://doi.org/10.1093/jnci/dju285
Terminal Duct Lobular Unit Involution of the Normal Breast: Implications for Breast Cancer Etiology
Jonine D. Figueroa and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju286, https://doi.org/10.1093/jnci/dju286
RE: Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence
Paul F. Pinsky
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju292, https://doi.org/10.1093/jnci/dju292
Response
Pär Stattin and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju293, https://doi.org/10.1093/jnci/dju293
Molecular Subtypes of High-Grade Serous Ovarian Cancer: The Holy Grail?
Levi Waldron and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju297, https://doi.org/10.1093/jnci/dju297
Colorectal Cancer Survivors Need Better Follow-Up Care
Gunjan Sinha
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju338, https://doi.org/10.1093/jnci/dju338
FDA Considers Restricting or Banning Laparoscopic Morcellation
Vicki Brower
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju339, https://doi.org/10.1093/jnci/dju339
PDQ (Physician Data Query)
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju340, https://doi.org/10.1093/jnci/dju340
Resistant Starch May Reduce Colon Cancer Risk From Red Meat
Judy Peres
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju341, https://doi.org/10.1093/jnci/dju341
Stat Bite Percentage of New Cases of Colorectal Cancer in the United States per 100 000 (2007–2011)
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju342, https://doi.org/10.1093/jnci/dju342
Beyond Counting: New Way To Use Circulating Tumor Cells
Anna Azvolinsky
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju343, https://doi.org/10.1093/jnci/dju343
The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length
Mark M. Iles and others
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, October 2014, dju267, https://doi.org/10.1093/jnci/dju267
Advertisement
Advertisement